Exogems

Exogems is a French biotechnology company specializing in the development of exosome-based solutions for oncology. The company leverages extracellular vesicles (exosomes) to develop both innovative therapeutic delivery systems and non-invasive diagnostic tools. By utilizing the natural properties of exosomes to transport bioactive molecules, Exogems aims to improve the targeting and efficacy of cancer treatments while reducing systemic toxicity. Their research is primarily focused on identifying specific exosomal signatures for early cancer detection and monitoring. The company is a spin-off from the Montpellier Cancer Research Institute (IRCM) and utilizes proprietary technology for the isolation and characterization of high-purity exosomes.